You are here

Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Incheon, , 405-760 Korea, Republic of
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Gram-Positive Bacterial Infections
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- All patients admitted to or transferred to the SICU.

- Eligible patients will be patients of either sex, 18 years of age or older who are
admitted or transferred to the SICU.

- Provide written informed consent

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients who have hypersensitivity to penicillin, cephalosporins or beta-lactamase
inhibitors.

- Females who are pregnant and breast feeding

- Any underlying conditions or non-infectious diseases that will be ultimately fatal
within 48 hours.

- Those who have already been participating other clinical study related with
antibiotics.

NCT00167960
Pfizer
Completed
Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now